The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Abaxis is facing stiff competition in the market for pet diagnostics. () California-based diagnostics maker Abaxis ($ABAX), which derives most of its revenues from ...

On Nov 20, Zacks Investment Research upgraded home health and hospice care provider Abaxis Inc. (ABAX) to a Zacks Rank #2 (Buy). We are impressed with Abaxis' encouraging second-quarter fiscal 2015 ...

UNION CITY, Calif., Oct. 31, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company has signed ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/27/15, Abaxis, Inc. (NASD: ABAX), Teleflex Incorporated (NYSE: TFX), and Chemed Corp (NYSE: CHE) will all trade ex-dividend for ...

According to Abaxis, enriched with all necessary critical chemistry analytes, this KPP rotor is perfectly fit to diagnose and monitor kidney disease in animals. The company also claims that this ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

UNION CITY, Calif., Oct. 1, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and ...

Abaxis (ABAX) reported its second straight earnings miss on October 22 as revenue came in below expectations and profit margins contracted. Analysts revised their estimates meaningfully lower for both ...

(Reuters) - Top animal health company Zoetis Inc (ZTS.N) will buy Abaxis Inc (ABAX.O) for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics ...

Abaxis (Nasdaq: ABAX) reported earnings on Jan. 31. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 31 (Q3), Abaxis beat expectations on revenues and beat ...